is this you? Claim your profile.
is this you? Claim your profile.
HQ Phone:  (800) 798-6972
Direct Phone: (210) ***-****
+ Get 10 Free Contacts a Month
It's free and takes 30 seconds
1217 Somerset Ave
Executive Vice President, Associate Medical Director
Diartis Pharmaceuticals Inc
other professional organization
American Association of Clinical Endocrinologists Organization
American Diabetes Association Organization
The Endocrine Society Organization
Bachelor of Science degree
Philadelphia College of Textiles and Sciences
Mark S. Kipnes, M.D. Andrew J. Lewin, MD¹, Mark S. Kipnes, MD², Luigi F. Meneghini, MD³, Diane J. Plotkin,Mark S. Kipnes, MD1; Paresh Dandona, MD2; Devjit Tripathy; MD2; J. Gordon Still, PhD3.; Gordana Kosutic, MD3 Diabetes Care Volume 26, Number 2, February 2003, pp:421-426, 2003. Mark S. Kipnes, M.D., Sawn M. Bina, M.D.Jerome S. Fischer, M.D., Mark S. Kipnes, M.D., Amna A. Salhin, M.D., Daina Dreimane, M.D. Litza Loza.Mario R. W. Ehlers, M.D., Roderick E. Harley, M.D., Roberta L. Schneider, M.D., Mark S. Kipnes, M.D..Mark S. Kipnes, et al., published in The American Journal of Medicine, July 2001, Volume 111, Number 1, published by Elsevier Science. "Sugar-Free Zinc Gluconate Glycine Lozenges (Cold Eeze®) Do Not Adversely Affect Glucose Control in Patients with Type 1 or Type 2 Diabetes Mellitus".Sherwyn L. Schwartz, M.D.; Jerome S. Fischer, M.D.; Mark S. Kipnes, M.D. American Journal Of Therapeutics, 1075-2765 © 2001 Lippincott Willisms & Wilkins pp.Terri Ryan, RN, CDE; Jasso-Glavy, Carla, MS, RD, CDE; Kipnes, Mark S., M.D. and their health care team.Jabri, Nabeel, MD. ; Schalch, Don S., MD; Schwartz, Sherwyn L. , MD; Fischer, Jerome S., MD; Kipnes, Mark S., MD; Radnik, Barbara J., RN; Turman, Nancy J., MD; Marcisin , Victoria S., MD and Guler, Hans-Peter, MD. Diabetes, A Journal of the American Diabetes Association, March 1994, Volume 43Schwartz, Sherwyn, MD; Fischer, Jerome S., MD; Kipnes, Mark S., MD and Boyle, Mary, RN., The American Journal of Medicine, September 18, 1987, Volume 83, Supplement 3A, pp.Mark S. Kipnes, MD¹, Prachi K. Drandekar, Pharm.D.². Friday, April 30, 2004 from 9:45 to 10:30 a.m. Andrx Labs, Inc., 411 Hackensack Ave., Hackensack, New Jersey 07601, U.S.A.Mark S, Kipnes, MD¹, Prachi K. Drandekar, Pharm.D.². Friday, April 30, 2004 from 9:45 to 10:30 a.m. Andrx Labs., Inc., 411 Hackensack Ave., Hackensack, New Jersey 07601, U.S.A.DANIEL EINHORN, MARK KIPNES, N. BRADLEY GLAZER, WILLIAM WISHNER, PIOGLITAZONE STUDY GROUP.Mark S. Kipnes, Sherwyn L. Schwartz, Jerome S. Fischer, William F. Trigoso, Amna A. Salhin, Jacob Vadakekalam, Daina Dreimane, William D. Linn.Parts of this work were presented at the 59th Annual Meeting and Scientific Sessions of the American Diabetes Association, June 19-20, 1999, San Diego, California, and published as an abstract in Diabetes, Supplement 1, May 1999. *Members of the Pioglitazone 027 Study Group are listed in the Acknowledgements. *Mark S. Kipnes: Part of 027 the Study Group. "A Comparison of the Pharmacodynamic Effects of Inhaled Insulin versus Subcutaneous Insulin in Type 1 Diabetic Patients".MARK KIPNES, BABATUNDE OTULANA, PER CLAUSON, JEROME FISCHER, STEPHEN J. FARR, VIBEKE HATORP, SHERWYN SCHWARTZ, HAYWARD, CA. Diabetes, A Journal of the American Diabetes Association, Abstract Book, 59th Scientific Sessions, May 1999, Volume 48, Supplement I, pp.Anne Klibanski, M.D.1, Mark Kipnes, M.D.2, David Kleinberg, M.D. 3, David Cook, M.D.4, Peter Snyder, M.D.5, Maria Walker6 and Daniel Odenheimer, PhD7. Jerome S. Fischer, M.D. Riad G. Dirani, M.D., Sherwyn L. Schwartz, M.D., Mark S. Kipnes, M.D., Fernando W. Trigoso, M.D., Amna A. Salhin, M.D., Jacob Vadakekalam, M.D., Daina Dreimane, M.D., Litza Loza, San Antonio, Texas.Stephen Clement, M.D., Mark S. Kipnes, M.D., Helmut Steinberg, M.D., S. Edwin Fineberg, M.D., Louis Jovanovic, M.D., Nancy Rikalo, M.D., Jennifer Marks, M.D., Diana Gibson, M.D., J. Gordon Still, M.D., Gordana Kosutic, M.D. For presentation at the American Diabetes Association 62nd Scientific Sessions, June 14-18, 2002, San Francisco, California.Mark S. Kipnes, Paresh Dandona, J. Gordon Still, Gordana Kosutic.Kipnes, B. Otulana, S. Farr, J. Jendle, J. Thipphawong and S. Schwartz.For presentation at the 36th Annual Meeting of The European Association for the Study of Diabetes, held at the Jerusalem ICC - International Convention Center and the adjacent Crowne Plaza Hotel, September 18, 2000, Jerusalem, Israel."Effects of Troglitazone on HbA1c and ALT Levels in Clinical Practice".Sherwyn L. Schwartz, M.D., Jerome S. Fischer, M.D., Mark S. Kipnes, M.D., San Antonio, TX. For presentation at the President's Poster Session and Reception, American Diabetes Association 59th Scientific Sessions, June 20, 1999, San Diego, CA.
Diabetes & Glandular Disease Clinic, P.A. | Home
Mark S. Kipnes, M.D.
Weight Loss Surgery - Methodist Healthcare System | San Antonio, TX
Mark S. Kipnes, MD
Mark S. Kipnes, MD View Physician Profile Endocrinology Internal Medicine Diabetes & Glandular Disease Center 5107 Medical Dr. San Antonio, TX 78229
Encapsulation Systems, Inc. - News & Events
Diabetes & Glandular Associates; San Antonio, Texas (Mark Kipnes, MD): HPT-1 trial
SB-509," commented the presenter, Mark Kipnes, M.D., lead investigator on the Phase 1 trial and an endocrinologist at the Diabetes and Glandular Disease Clinic, San Antonio, Texas.